3795-69-5

Basic information

• Product Name: METHYL-B-L-ARABINOPYRANOSIDE APPROX.
• Synonyms: METHYL-B-L-ARABINOPYRANOSIDE APPROX.;METHYL-B-L-ARABINOPYRANOSIDE, APPROX.*97 % BY CAPILL;β-methyl l-arabinoside
• CAS NO: 3795-69-5
• Molecular Formula: C₆H₁₂O₅
• Molecular Weight: 164.15648
• Product Categories: Sugars, Carbohydrates & Glucosides
• Mol File: 3795-69-5.mol
• Article Data: 84

Chemical Properties

• Boiling Point: 314°Cat760mmHg
• Flash Point: 143.7°C
• Appearance: /
• Density: 1.4g/cm³
• CAS DataBase Reference: METHYL-B-L-ARABINOPYRANOSIDE APPROX.(CAS DataBase Reference)
• NIST Chemistry Reference: METHYL-B-L-ARABINOPYRANOSIDE APPROX.(3795-69-5)
• EPA Substance Registry System: METHYL-B-L-ARABINOPYRANOSIDE APPROX.(3795-69-5)

Safety Data

• Hazardous Substances Data: 3795-69-5(Hazardous Substances Data)

Upstream product

• 67-56-1 methanol 
• 532-20-7 D-Ribose 
• 50-69-1 D-ribose 
• 1114-34-7 D-lyxose 
• 110065-28-6 methyl 2,5-di-O-caffeyl-α-L-arabinofuranoside 
• 87-72-9 L-(+)-arabinose 
• 5328-37-0 L-arabinose 
• 609-06-3 L-xylose 
• 532-20-7 D-xylofuranose 
• 75-36-5 acetyl chloride 
• 87-72-9 D-Xylose 
• 58-86-6 D-xylose 
• 36468-53-8 β-D-ribofuranose 
• 63846-98-0 1,2-O-(1-Methylethylidene)-α-D-ribo-pentodialdo-1,4-furanose 

Downstream Products

• 86042-33-3 methyl 2,3,5-tri-O-p-toluyl-D-ribofuranoside 
• 459426-88-1 (4R,5R)-5-((S)-2-Benzyloxy-1-hydroxy-2-methyl-propyl)-2,2-dimethyl-[1,3]dioxolane-4-carbaldehyde 
• 459426-89-2 (S)-2-Benzyloxy-1-((4R,5S)-5-hydroxymethyl-2,2-dimethyl-[1,3]dioxolan-4-yl)-2-methyl-propan-1-ol 
• 459426-96-1 2-Benzyloxy-1-((4S,5S)-5-benzyloxymethyl-2,2-dimethyl-[1,3]dioxolan-4-yl)-2-methyl-propan-1-one 
• 459426-91-6 (4S,5S)-4-((S)-2-Benzyloxy-1-methoxy-2-methyl-propyl)-5-benzyloxymethyl-2,2-dimethyl-[1,3]dioxolane 
• 459426-98-3 (4S,5S)-4-((R)-2-Benzyloxy-1-methoxy-2-methyl-propyl)-5-benzyloxymethyl-2,2-dimethyl-[1,3]dioxolane 
• 459426-90-5 (S)-2-Benzyloxy-1-((4R,5S)-5-benzyloxymethyl-2,2-dimethyl-[1,3]dioxolan-4-yl)-2-methyl-propan-1-ol 
• 459426-97-2 (R)-2-Benzyloxy-1-((4R,5S)-5-benzyloxymethyl-2,2-dimethyl-[1,3]dioxolan-4-yl)-2-methyl-propan-1-ol 
• 303041-43-2 1-O-acetyl-2,3,5-tri-O-[3-(trifluoromethyl)benzoyl]-D-ribofuranoside 
• 303041-44-3 2',3',5'-tri-O-[3-(trifluoromethyl)benzoyl]uridine 
• 303041-45-4 2',3',5'-tri-O-[3-(trifluoromethyl)benzoyl]-5-methyluridine 
• 59279-39-9 2,5-anhydro-3,4,6-tri-O-(p-nitrobenzoyl)-D-allononitrile 
• 63527-43-5 2,3,5-p-Nitrobenzoyl-D-ribofuranosylbromid 
• 86042-35-5 2,3,5-tri-O-p-toluyl-D-ribofuranosyl bromide 

Relevant articles and documents

MODIFIED OLIGOMERIC COMPOUNDS AND USES THEREOF

The present disclosure provides oligomeric compounds comprising a modified oligonucleotide having at least one stereo-non-standard nucleoside. An oligomeric compound comprising a modified oligonucleotide consisting of 12-30 linked nucleosides, wherein at least one nucleoside of the modified oligonucleotide is a stereo-non-standard nucleoside; and wherein the oligomeric compound is selected from among an RNAi compound, a modified CRISPR compound, and an artificial mRNA compound.

Novel saccharide bio-based cyclic phosphorus/phosphonate as well as preparation method and application thereof

The invention discloses novel saccharide bio-based cyclic phosphorus/phosphonate as well as a preparation method and application thereof, and belongs to the field of compounds. The cyclic phosphorus/phosphonate is prepared by the following steps: reacting D-xylose with acetyl chloride to obtain an intermediate product, and then reacting with dichlorophosphate or phosphonic dichloride under the action of an acid-binding agent to obtain a target product. The preparation method is high in yield, simple in process, low in raw material cost and small in environmental pollution, and the prepared cyclic phosphorus/phosphonate flame retardant is outstanding in flame retardance and easy to industrialize.

Substituted pyrazole compound, preparation method, pharmaceutical composition and applications thereof

The invention discloses a substituted pyrazole compound represented by a formula I, and a preparation method, a pharmaceutical composition and applications thereof, wherein the compound has characteristics of good stability, excellent solubility, low cytotoxicity and remarkable neuroprotective effect, can effectively prevent and treat nerve cell injury, and is an ideal medicinal compound for preventing or treating cerebral stroke, cerebral embolism, cerebral stroke sequelae, cerebral stroke dyskinesia, mitochondrial encephalomyopathy and amyotrophic lateral sclerosis of spinal cord.